Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Gynecomastia × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1414 Carcinoma, Renal Cell 579 Urinary Bladder Neoplasms 366 Kidney Neoplasms 255 Carcinoma, Transitional Cell 189 Neoplasm Metastasis 163 Neoplasms 122 Melanoma 83 Breast Neoplasms 80 Carcinoma, Non-Small-Cell Lung 76 Testicular Neoplasms 66 Ovarian Neoplasms 62 Sarcoma 55 Urethral Neoplasms 51 Non-Muscle Invasive Bladder Neoplasms 50 Wilms Tumor 49 Lung Neoplasms 45 Colorectal Neoplasms 42 Neuroblastoma 39 Uterine Cervical Neoplasms 37 Penile Neoplasms 37 Pancreatic Neoplasms 37 Urologic Neoplasms 34 Recurrence 32 Lymphoma, Non-Hodgkin 32 Ureteral Neoplasms 28 Osteosarcoma 28 Testicular Germ Cell Tumor 26 Head and Neck Neoplasms 26 Stomach Neoplasms 25

Interventions

bicalutamide 1 Tamoxifen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00637871 2011-01-24

Casodex - Nolvadex Combination

AstraZeneca

Phase 2 Completed

Gynecomastia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡